Clinical Trials Logo

Clinical Trial Summary

The purpose of the study is to verify and validate the parameters collected from mobile devices via the app named "Comestai" and from reference devices. The assessments considered to define comorbidities are included.. Specifically, collection of vital parameters (Blood Pressure, Heart Rate, Respiratory Rate, Oxygen Saturation) through the "Comestai" Application via mobile phones (using photoplethysmographic method) and reference devices such as Withings-Blood Pressure Monitor Connect® (for Blood Pressure), Polar Verity Sense® (for Heart Rate), Masimo-finger sensor® (for Oxygen Saturation, Respiratory Rate), comparing and confirming them. Consent will be sought for the viewing and collection of blood test results that are normally included in evaluations for subjects with overweight and/or obesity and/or diabetes. Estimated time required for each measurement recording: 10-15 minutes per subject Total number of subjects: 3000


Clinical Trial Description

Early detection of variations in vital parameters allows for the identification of changes in patients' health status and the provision of recommendations for therapeutic adjustments. The application named "Comestai" is a non-invasive and easy-to-use tool that enables the measurement of vital parameters. The app allows users to simultaneously measure vital parameters such as Heart Rate (HR), Respiratory Rate (RR), Oxygen Saturation (SpO2), and Blood Pressure (BP) using the photoplethysmographic method with the front camera of a mobile device. The use of simultaneous vital parameter measurement systems like apps can enhance self-monitoring of health status and improve patient care. In this study, vital parameters will be measured using the "Comestai" application and compared and validated with measurements from standard clinical practice devices. Consent will be sought for the viewing and collection of biochemical evaluation results typically required for individuals with overweight and/or obesity and/or diabetes. "Comestai" Application: This wellness app allows for non-invasive measurement of vital parameters, enabling users to detect SpO2, HR, RR, and BP by looking at the front camera of a mobile device ("By Face"). The measurement method used is Remote Photoplethysmography (rPPG). This is a prospective, open-label, study to collect vital parameters using the Comestai application by looking at the front camera of a mobile device ("By Face"). The measurement method of the app is Remote Photoplethysmography (rPPG). The study plans to enroll up to 3000 subjects Each subject will be assigned a specific identification number (Subject ID). During the evaluation, the following data will be recorded in the Electronic Case Report Form (eCRF): Medical history of the subject Current or past therapies Demographic data (date of birth, sex) Smoking habits Physical characteristics (height in meters, weight in kilograms, Body Mass Index in kg/m^2, and phototype) During the 'By Face' measurement of vital parameters with the app, subjects will be asked to sit in a comfortable place, looking at the phone screen (about 25 cm away) with their face fully uncovered (no masks, hats, or any facial accessories). During data collection, the subject should remain still and breathe steadily. The subject will be required to look directly at the camera throughout the data collection process. The 'By Face' data collection mode can be performed on both iOS and Android in parallel, with both devices positioned in front of the subject. HR and blood pressure will also be measured immediately before and after the app measurement. Data Collection Equipment For vital signs data collection using the "Comestai" application, the study staff will use the following mobile phones for rPPG "By Face" measurements: - Face: Apple internet(i)Phone 13 Pro (10 bit) & Samsung Galaxy S21 Ultra - Two additional phones will be used as remote: - One Android phone - Recorder Remote to start the measurement from far. - One Apple iPhone -Masimo-finger sensor App to collect the data from the Masimo finger sensor. - Other necessary equipment includes phone stands (two per room of measurement). In addition to the equipment for vital signs data collection using the "Comestai" application, reference devices will measure the subject's vital signs as a point of comparison. rPPG "By Face" vital signs data collection includes videoing the subjects' faces with a mobile device (iOS and Android) front camara for approximately 1.5 minutes. Vital signs data using the reference devices (i.e., SpO2, RR, BP, PR) will be collected continuously for approximately 1.5 minutes, and simultaneously to the data collected using the "Comestai" application (i.e., "By Face"). Several data collection events (1.5 minutes each) may be performed per subject using the "Comestai" application and reference devices. BP will be collected using the reference devices prior to data collection using the Comestai application and immediately after completion of data collection using the Comestai application. During "By Face" data collection, the subjects will be requested to sit in a comfortable place, looking at a screen (distance of ~25cm) with a fully exposed face (not to wear a mask, hat, or any kind of accessory on the face). During data collection, the subject breathing should be stable with minimum movements. The subject will be requested to stare directly towards the camara during the whole data collection process. "By Face" mode of data collection can be taken for both iOS and Android in parallel when both devices are positioned in front of the subject. During the "By Face" data collection, SpO2 levels will be monitored continuously using the standard reference device. Consent will be sought for viewing and collecting the results of pre-scheduled blood tests. Participation is optional, and subjects who do not consent can still proceed with the parameter measurements. In case of acceptance, the following results will be considered: Complete Blood Count (Hemoglobin, White Blood Cell Count, Neutrophils, Lymphocytes, and Platelets), Hemoglobin Glycosylated (HbA1C), Lipid Profile (Total Cholesterol, Cholesterol-LDL, Cholesterol-HDL, and Triglycerides), Glucose, Alanine transaminase (ALT), Creatinine. Estimated participation time per subject: approximately 10-15 minutes. No medical decisions will be based on data obtained through the "Comestai" application, reference devices, or blood sample results. All data will be recorded in the study's eCRF. The analysis plan involves verifying and validating the parameters collected from mobile devices via the app and from reference devices, as well as results of pre-scheduled blood tests and patient demographic data. For all parameters, the accuracy of the app measurement compared to the reference device and standard tests will be assessed. Confidence intervals will be calculated using the bootstrap method. The correlation between measurements using the app and those using reference devices and standard tests will be evaluated using the Pearson correlation coefficient. The agreement between the two measurements (app and reference devices/and standard tests) will be represented using Bland-Altman plots. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06427564
Study type Observational
Source Buzzi Children's Hospital
Contact Gianvincenzo Zuccotti, MD, Prof
Phone +390263631
Email gianvincenzo.zuccotti@unimi.it
Status Not yet recruiting
Phase
Start date June 1, 2024
Completion date June 1, 2025

See also
  Status Clinical Trial Phase
Recruiting NCT05908045 - Have Physical Therapists Attitudes and Beliefs Towards Vital Assessment Changed Following the COVID-19 Pandemic?
Enrolling by invitation NCT05975658 - WIReD: Wireless Interstage Remote Device Study
Completed NCT03143062 - The National Early Warning Score: Preceding Dynamics in the Score for Those Who Suffer an In-hospital Cardiac Arrest
Completed NCT03179267 - Detection of Deterioration by SNAP40 Versus Standard Monitoring in the ED N/A
Not yet recruiting NCT05023356 - Non-contact Vital Signs Monitoring in Anesthesia
Recruiting NCT05970614 - The Effect of Eye Masks and Earplugs In Intensive Care Unit Patients N/A
Completed NCT01448161 - A Machine Learning Approach to Continuous Vital Sign Data Analysis
Recruiting NCT05013411 - Rethinking Observations in Mental Health
Completed NCT04678050 - Dexmedetomidine Compared to Ketofol for Sedation in Paediatrics Phase 1
Not yet recruiting NCT04976907 - Peri-operative Mobile Application for Contactless Screening and Vital Signs Measurement
Completed NCT01157832 - Evaluation of the Acute Effect of Water-Pipe Smoking on the Respiratory System N/A
Completed NCT04003662 - Vital Sign Comparison Between Lifelight and Standard of Care - Development
Recruiting NCT05241483 - Remote Patient Monitoring and Detection of Possible Diseases With Artificial Intelligence Telemedicine System
Not yet recruiting NCT04627766 - Validation of Continuous Monitoring of Vital Signs in Children With a Connected Patch N/A
Completed NCT04997694 - Effect of Preoperative Active Warming and Passive Warming Methods on Perioperative Hypothermia N/A
Active, not recruiting NCT04935190 - Comparison of Resting Heart and Respiratory Rate Measurements Acquired by Contactless Radar Sensors, Electrocardiography, and Capnography
Completed NCT04935723 - The Effects of Reiki on Abdominal Surgery Patients' Anxiety, Fear, Postoperative Pain and Life Findings N/A
Completed NCT05131620 - Virtual Reality and Acupressure Applications; Effect on Pain, Anxiety, Vital Signs and Comfort N/A
Completed NCT02524470 - Vital Signs Patch Early Feasibility and Usability Study v1.0 N/A
Not yet recruiting NCT06465875 - The Effect of Book Reading on Comfort, Hope, Anxiety and Vital Signs of Intensive Care Unit Patients N/A